↓ Skip to main content

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis

Overview of attention for article published in Frontiers in Pharmacology, April 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
Published in
Frontiers in Pharmacology, April 2022
DOI 10.3389/fphar.2022.863677
Pubmed ID
Authors

Yi Luan, Hui Liu, Ying Luan, Yang Yang, Jing Yang, Kai-Di Ren

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 11%
Student > Bachelor 1 11%
Researcher 1 11%
Lecturer 1 11%
Student > Master 1 11%
Other 0 0%
Unknown 4 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 22%
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Medicine and Dentistry 1 11%
Unknown 5 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2022.
All research outputs
#20,941,352
of 23,571,271 outputs
Outputs from Frontiers in Pharmacology
#10,877
of 17,197 outputs
Outputs of similar age
#359,680
of 442,689 outputs
Outputs of similar age from Frontiers in Pharmacology
#769
of 1,277 outputs
Altmetric has tracked 23,571,271 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,197 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,689 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,277 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.